Abstract
Background ARTservices are expanding in Sub Saharan African countries. In Rwanda the demographic and health survey of 2005(DHS) showed a prevalence rate of 3%at national level and by the end of June 2009, 70234 persons had initiated ARV at 217 sites in Rwanda (TRACnet report June 2009). Kimironko health center has provided care and treatment to patients since 2003, at this point there are 1776 patients followed in the HIV clinic at this health center. It is important to evaluate immunologic responses and efficacy of antiretroviral therapy in resource poor settings.
Highlights
ARTservices are expanding in Sub Saharan African countries
First-line ART regimens contained Lamivudine (100%), Stavudine (68,3%), Zidovudine (31%), and either Efavirenz (14%) or Nevirapine (85,7%)
At ART initiation the median baseline CD4+ cell count was 192 cells per micro liter, the median CD4+ cell count increased by 90 cells per micro liter at 6 months(n = 393) [interquartile range (IQR) 191-372] and 112 cells per micro liter [IQR 230-408] at 12 months(n = 266)
Summary
ARTservices are expanding in Sub Saharan African countries. In Rwanda the demographic and health survey of 2005(DHS) showed a prevalence rate of 3%at national level and by the end of June 2009, 70234 persons had initiated ARV at 217 sites in Rwanda (TRACnet report June 2009). Kimironko health center has provided care and treatment to patients since 2003, at this point there are 1776 patients followed in the HIV clinic at this health center. It is important to evaluate immunologic responses and efficacy of antiretroviral therapy in resource poor settings
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.